Neoadjuvant Paclitaxel, Ifosfamide, and Cisplatin Chemotherapy for Metastatic Penile Cancer: A Phase II Study
Pagliaro, Lance C, Williams, Dallas L, Daliani, Danai, Williams, Michael B, Osai, William, Kincaid, Michael, Wen, Sijin, Thall, Peter F, Pettaway, Curtis A
Published in Journal of clinical oncology (20.08.2010)
Published in Journal of clinical oncology (20.08.2010)
Get full text
Journal Article
Phase II Clinical Trial of Neoadjuvant Alternating Doublet Chemotherapy With Ifosfamide/Doxorubicin and Etoposide/Cisplatin in Small-Cell Urothelial Cancer
SIEFKER-RADTKE, Arlene O, KAMAT, Ashish M, BARTON GROSSMAN, H, WILLIAMS, Dallas L, WEI QIAO, THALL, Peter F, DINNEY, Colin P, MILLIKAN, Randall E
Published in Journal of clinical oncology (01.06.2009)
Published in Journal of clinical oncology (01.06.2009)
Get full text
Journal Article
A Phase 2 Clinical Trial of Sequential Neoadjuvant Chemotherapy With Ifosfamide, Doxorubicin, and Gemcitabine Followed by Cisplatin, Gemcitabine, and Ifosfamide in Locally Advanced Urothelial Cancer: Final Results
SIEFKER-RADTKE, Arlene O, DINNEY, Colin P, YU SHEN, WILLIAMS, Dallas L, KAMAT, Ashish M, BARTON GROSSMAN, H, MILLIKAN, Randall E
Published in Cancer (01.02.2013)
Published in Cancer (01.02.2013)
Get full text
Journal Article
Neoadjuvant platelet derived growth factor receptor inhibitor therapy combined with docetaxel and androgen ablation for high risk localized prostate cancer
Mathew, Paul, Pisters, Louis L, Wood, Christopher G, Papadopoulos, John N, Williams, Dallas L, Thall, Peter F, Wen, Sijin, Horne, Erin, Oborn, Carol J, Langley, Robert, Fidler, Isaiah J, Pettaway, Curtis A
Published in The Journal of urology (01.01.2009)
Published in The Journal of urology (01.01.2009)
Get more information
Journal Article
Gemcitabine modulation of alkylator therapy : A Phase I trial of escalating gemcitabine added to fixed doses of ifosfamide and doxorubicin
MILLIKAN, Randall E, PLUNKETT, William K, SMITH, Terry L, WILLIAMS, Dallas L, LOGOTHETIS, Christopher J
Published in Cancer (01.07.2001)
Published in Cancer (01.07.2001)
Get full text
Journal Article
Treatment of refractory urothelial carcinoma with alternating paclitaxel, methotrexate, cisplatin (TMP) and 5-fluorouracil, α-interferon, cisplatin (FAP)
Tu, Shi-Ming, Millikan, Randall E., Pagliaro, Lance C., Daliani, Danai, Papandreou, Christos N., Kim, Jeri, Chen, Dung-Tsa, Williams, Dallas L., Logothetis, Christopher J.
Published in Urologic oncology (01.09.2003)
Published in Urologic oncology (01.09.2003)
Get full text
Journal Article
A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer
Siefker‐Radtke, Arlene O., Dinney, Colin P., Shen, Yu, Williams, Dallas L., Kamat, Ashish M., Grossman, H. Barton, Millikan, Randall E.
Published in Cancer (01.02.2013)
Published in Cancer (01.02.2013)
Get full text
Journal Article
Gemcitabine modulation of alkylator therapy
Millikan, Randall E., Plunkett, William K., Smith, Terry L., Williams, Dallas L., Logothetis, Christopher J.
Published in Cancer (01.07.2001)
Published in Cancer (01.07.2001)
Get full text
Journal Article
BARIUM: RATIONALE FOR A NEW ORAL REFERENCE DOSE
Dallas, C E, Williams, P L
Published in Journal of toxicology and environmental health. Part B, Critical reviews (01.10.2001)
Published in Journal of toxicology and environmental health. Part B, Critical reviews (01.10.2001)
Get full text
Journal Article